211 related articles for article (PubMed ID: 19394254)
1. QSAR analysis for quinoxaline-2-carboxylate 1,4-di-N-oxides as anti-mycobacterial agents.
Vicente E; Duchowicz PR; Castro EA; Monge A
J Mol Graph Model; 2009 Aug; 28(1):28-36. PubMed ID: 19394254
[TBL] [Abstract][Full Text] [Related]
2. Exploring 3-arylquinoxaline-2-carbonitrile 1,4-di-N-oxides activities against neglected diseases with QSAR.
Vicente E; Duchowicz PR; Ortiz Edel V; Monge A; Castro EA
Chem Biol Drug Des; 2010 Jul; 76(1):59-69. PubMed ID: 20492446
[TBL] [Abstract][Full Text] [Related]
3. Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides.
Vicente E; Duchowicz PR; Benítez D; Castro EA; Cerecetto H; González M; Monge A
Bioorg Med Chem Lett; 2010 Aug; 20(16):4831-5. PubMed ID: 20634064
[TBL] [Abstract][Full Text] [Related]
4. QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors.
Dolezal R; Van Damme S; Bultinck P; Waisser K
Eur J Med Chem; 2009 Feb; 44(2):869-76. PubMed ID: 18547684
[TBL] [Abstract][Full Text] [Related]
5. New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents.
Torres E; Moreno E; Ancizu S; Barea C; Galiano S; Aldana I; Monge A; Pérez-Silanes S
Bioorg Med Chem Lett; 2011 Jun; 21(12):3699-703. PubMed ID: 21570839
[TBL] [Abstract][Full Text] [Related]
6. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A
Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
Jaso A; Zarranz B; Aldana I; Monge A
J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
[TBL] [Abstract][Full Text] [Related]
8. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
Vicente E; Pérez-Silanes S; Lima LM; Ancizu S; Burguete A; Solano B; Villar R; Aldana I; Monge A
Bioorg Med Chem; 2009 Jan; 17(1):385-9. PubMed ID: 19058970
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A
Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380
[TBL] [Abstract][Full Text] [Related]
10. On application of constitutional descriptors for merging of quinoxaline data sets using linear statistical methods.
Ghosh P; Vracko M; Chattopadhyay AK; Bagchi MC
Chem Biol Drug Des; 2008 Aug; 72(2):155-62. PubMed ID: 18637990
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives.
Puratchikody A; Natarajan R; Jayapal M; Doble M
Chem Biol Drug Des; 2011 Dec; 78(6):988-98. PubMed ID: 21951363
[TBL] [Abstract][Full Text] [Related]
13. A theoretical study of a family of new quinoxaline derivatives.
Diez RP; Duchowicz PR; Castañeta H; Castro EA; Fernández FM; Albesa AG
J Mol Graph Model; 2006 Dec; 25(4):487-94. PubMed ID: 16682241
[TBL] [Abstract][Full Text] [Related]
14. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones.
Ramalingam P; Ganapaty S; Rao ChB
Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890
[TBL] [Abstract][Full Text] [Related]
15. QSAR study of antimicrobial activity of some 3-nitrocoumarins and related compounds.
Debeljak Z; Skrbo A; Jasprica I; Mornar A; Plecko V; Banjanac M; Medić-Sarić M
J Chem Inf Model; 2007; 47(3):918-26. PubMed ID: 17489552
[TBL] [Abstract][Full Text] [Related]
16. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.
Ortega MA; Sainz Y; Montoya ME; Jaso A; Zarranz B; Aldana I; Monge A
Arzneimittelforschung; 2002; 52(2):113-9. PubMed ID: 11878199
[TBL] [Abstract][Full Text] [Related]
17. Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study.
Rivera G; Andrade-Ochoa S; Romero MSO; Palos I; Monge A; Sanchez-Torres LE
Anticancer Agents Med Chem; 2017; 17(5):682-691. PubMed ID: 27396382
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives.
Moorthy NS; Karthikeyan C; Trivedi P
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):394-405. PubMed ID: 20233012
[TBL] [Abstract][Full Text] [Related]
19. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
20. Studies on log Po/w of quinoxaline di-N-oxides: a comparison of RP-HPLC experimental and predictive approaches.
Moreno E; Gabano E; Torres E; Platts JA; Ravera M; Aldana I; Monge A; Pérez-Silanes S
Molecules; 2011 Sep; 16(9):7893-908. PubMed ID: 22143549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
